Quantify’s Josefine Röhss and Hanna Fues-Wahl will be attending the Future of Swedish and Danish Life Science conference in Lund, Sweden, 22nd of March. We hope to see you there!
2017 was a busy and exciting year for the real-world evidence (RWE) team at Quantify. We have published more than ten scientific articles and presented more than a dozen research abstracts and posters at scientific conferences.
The Nordic Osteoporosis Research Database
Much […]
Anders Gustavsson co-authored an article on the cost, quality of life and survival in patients after stroke, published in the European Stroke Journal. As expected, the study demonstrates worse outcomes for patients with worse functioning 6 months post stroke. See […]
Quantify will be well-represented at this year’s European ISPOR congress, which is held in Glasgow, Scotland. We will be presenting some of our latest research and display our company in the exhibition hall.
We welcome the opportunity to meet with you! […]
Quantify will be represented at EUROSPINE 2017 in Dublin 11-13 October 2017. Emma Jonsson will present two posters, titled “Surgical outcome categorisation using global assessment (GA)” and “Cost of low back pain: results from a register study in […]
The paper “Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control” has been published in Archives of Osteoporosis. Linda Karlsson, Johan Mesterton, and Oskar Ström of Quantify are […]
The paper “A health economic lifetime treatment pathway model for low back pain in Sweden” has been published in the Journal of Medical Economics. Quantify’s Gylfi Olafsson, Emma Jonsson, and Fredrik Borgström are among the co-authors of the paper. […]
The abstract “The treatment gap after fracture in osteoporosis patients in Sweden”, co-authored by Jonas Banefelt, Linda Karlsson, Gustaf Ortsäter, and Oskar Ström of Quantify, was selected as a top 6 poster presentation at the 6th Global Congress of The […]
The paper “Real-world costs of autosomal dominant polycystic kidney disease in the Nordics” has been published in BMC Health Services Research. Linda Karlsson and Oskar Eklund of Quantify Research are among the co-authors of the paper. Pubmed link
Quantify has reviewed the new guidance on reimbursement applications for hospital pharmaceuticals in Denmark and has summarized the requirements and implications for the pharmaceutical industry. Economic analysis is now mandatory for submissions and along with medical effectiveness forms the basis for […]